The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Self-citationWild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
Self-citationEnfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
Lalezari, J. P., Henry, K., O'Hearn, M., Montaner, J. S. G., Piliero, P. J., Trottier, B., Walmsley, S., Cohen, C., Kuritzkes, D. R., Eron, J. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035026 · Cited by 914
Self-citationEfficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Lazzarin, A., Clotet, B., Cooper, D., Reynes, J., Arastéh, K., Nelson, M., Katlama, C., Stellbrink, H.-J., Delfraissy, J.-F., Lange, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035211 · Cited by 656
Self-citationStrategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Wild, C., Oas, T., McDanal, C., Bolognesi, D., & Matthews, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10537 · Cited by 485
Self-citationTrkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090576697 · Cited by 426
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Self-citationRichman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
Self-citationOligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1
Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K., & Zolla-Pazner, S. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2674-2679.1989 · Cited by 291
Muñoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., & Blumenthal, R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.315 · Cited by 280
Novel Therapies Based on Mechanisms of HIV-1 Cell Entry
Kilby, J. M., & Eron, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022812 · Cited by 254
Wild, C., Dubay, J. W., Greenwell, T., Baird, T., Oas, T. G., McDanal, C., Hunter, E., & Matthews, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12676 · Cited by 200
Self-citationKilby, J. M., Lalezari, J. P., Eron, J. J., Carlson, M., Cohen, C., Arduino, R. C., Goodgame, J. C., Gallant, J. E., Volberding, P., Murphy, R. L., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202760072294 · Cited by 198
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Zhang, Z., O'Brien, W. A., Ratner, L., Shaw, G. M., & Hunter, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8605-8614.2001 · Cited by 182
Chen, C. H., Matthews, T. J., McDanal, C. B., Bolognesi, D. P., & Greenberg, M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3771-3777.1995 · Cited by 169
Self-citationLalezari, J. P., Eron, J. J., Carlson, M., Cohen, C. J., DeJesus, E., Arduino, R. C., Gallant, J. E., Volberding, P. A., Murphy, R. L., Valentine, F. T., et al. (2003) · AIDS · doi:10.1097/00002030-200303280-00007 · Cited by 150
Mode of Action of an Antiviral Peptide from HIV-1
Kliger, Y., Gallo, S. A., Peisajovich, S. G., Muñoz‐Barroso, I., Avkin, S., Blumenthal, R., & Shai, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004113200 · Cited by 144
LaBranche, C. C., GALASSO, G., Moore, J. P., Bolognesi, D. P., Hirsch, M., & Hammer, S. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00130-9 · Cited by 105
Self-citationStrong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100
Tremblay, C. C. L., Kollmann, C. S., Giguel, F. F., Chou, T., & Hirsch, M. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010010-00001 · Cited by 98
Tremblay, C. L., Giguel, F. F., Kollmann, C. S., Guan, Y., Chou, T., Baroudy, B. M., & Hirsch, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1336-1339.2002 · Cited by 86
Lalezari, J. P., DeJesus, E., Northfelt, D., Richmond, G. J., Wolfe, P., Haubrich, R., Henry, D. A., Powderly, W. G., Becker, S. L., Thompson, M., et al. (2003) · Antiviral Therapy · doi:10.1177/135965350300800403 · Cited by 79
Self-citationLong-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era
King, J. T., Justice, A. C., Roberts, M. S., Chang, C.-C. H., & Fusco, J. S. (2003) · Medical Decision Making · doi:10.1177/0272989x02239652 · Cited by 77
Structural Rearrangements in the Transmembrane Glycoprotein after Receptor Binding
Matthews, T. J., Wild, C. T., Chen, C., Bolognesi, D. P., & Greenberg, M. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00866.x · Cited by 63
Self-citationThe school health nurse's assessment of a successful health dialogue
Borup, I. K. (2002) · Health & Social Care in the Community · doi:10.1046/j.0966-0410.2001.00337.x · Cited by 52
Entry Inhibitors SCH-C, RANTES, and T-20 Block HIV Type 1 Replication in Multiple Cell Types
Ketas, T. J., Klasse, P. J., Spenlehauer, C., Nesin, M., Frank, I., Pope, M., Strizki, J., Reyes, G. R., Baroudy, B. M., & Moore, J. P. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203763315678 · Cited by 45
Takashima, K., Miyake, H., Furuta, R. A., Fujisawa, J., Iizawa, Y., Kanzaki, N., Shiraishi, M., Okonogi, K., & Baba, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3538-3543.2001 · Cited by 22
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Tang, T., Bidon, M., Jaimes, J. A., Whittaker, G. R., & Daniel, S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104792 · Cited by 761
Metadata
- Authors
- Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-03-01
- Volume
- 3
- Issue
- 3
- Pages
- 215-225
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1542320852
- Cited by
- 465
- References
- 34
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.